AWMDMG
CLRB icon

Austin W. Marxe & David M. Greenhouse’s Cellectar Biosciences CLRB Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.3M Buy
+74
New +$6.39M 0.45% 72

Other funds holding CLRB

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's CLRB Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse opened a new position in Cellectar Biosciences (CLRB) in Q3 2014: 74 shares worth $3.3M. The stake represents 0.45% of the portfolio and ranks #72 among its holdings.

6 funds tracked by Wall St. Rank hold CLRB as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 74 shares of Cellectar Biosciences worth $3.3M as of Q3 2014.
  • Cellectar Biosciences was a new Austin W. Marxe & David M. Greenhouse position in Q3 2014.
  • Cellectar Biosciences made up 0.45% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #72 holding.
  • 6 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.